AI as a Medical Device

Written By

sophie vo Module
Sophie Vo

Associate
UK

I am a Senior Associate in the Intellectual Property Group in London with a particular focus on the life sciences and healthcare sectors.

Last month, the Medicines & Healthcare products Regulatory Agency (“MHRA“) published guidance on “Software and Artificial Intelligence (AI) as a Medical Device”. It didn’t necessarily provide for any new regulatory approach to AI in the therapeutic space, but it brought together some important material during this period of increasing interest in AI to effectively remind software providers of their compliance obligations in the life sciences and healthcare space.

Latest insights

More Insights
featured image

Transatlantic Tumult Triggering ESG Setbacks?

4 minutes Aug 22 2025

Read More
Curiosity line pink background

Cleared for Penalties: Webjet’s Misleading Consumer Practices Don’t Fly with the Federal Court

Aug 15 2025

Read More
Curiosity line yellow background

Hong Kong’s Clinics to Prepare for Licensing Regime

Aug 13 2025

Read More